All coverage
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
By Manojna Maddipatla & Lewis Krauskopf
New antiviral drug prevents half of severe COVID-19 infections
By Karen Weintraub
Merck could make up to $7 billion from its Covid-19 drugs in 2021
By Annalisa Merelli
Merck Pill Intended to Treat Covid-19 Succeeds in Key Study
By Betsy McKay & Jared S. Hopkins
How Merck's antiviral pill could change the game for COVID-19
By Meryl Davids Landau
Merck says its new Covid pill reduces the risk of hospitalization, death by half for some patients
By Chloe Taylor
Merck says experimental Covid pill cuts risk of death, hospitalization by 50 percent
By Erika Edwards
What would an antiviral pill mean for the fight against Covid-19?
By Virginia Langmaid
Coronavirus: Covid News: U.S. Parents' Views Are Shifting on Vaccines (Published 2021)
By Benjamin Mueller, Shawn Hubler & Rebecca Robbins